Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Griffin

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Plos One|October 17, 2013
Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgACristina Antonella Nadalutti, Ilma Rita Korponay-Szabo, Katri Kaukinen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2010
Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?Linghong Huang, John L Haylor, Marie Fisher, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 18, 2008
Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarringMarie Fisher, Richard A Jones, Linghong Huang, et al.
The Journal of Biological Chemistry|October 9, 2010
RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signalingZhuo Wang, Russell J Collighan, Stephane R Gross, et al.
Intensive Care Medicine|January 31, 2002
Continuous versus intermittent renal replacement therapy: a meta-analysisJohn A Kellum, Derek C Angus, John P Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2008
Synthesis of potent water-soluble tissue transglutaminase inhibitorsMartin Griffin, Alexandre Mongeot, Russell Collighan, et al.
Frontiers in Oncology|December 12, 2022
Corrigendum: <i>CDKN2A</i> determines mesothelioma cell fate to EZH2 inhibitionGiulia Pinton, Zhuo Wang, Cecilia Balzano, et al.
The Journal of Biological Chemistry|May 24, 2008
Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signalingDilek Telci, Zhuo Wang, Xiaoling Li, et al.
Frontiers in Oncology|July 19, 2021
<i>CDKN2A</i> Determines Mesothelioma Cell Fate to EZH2 InhibitionGiulia Pinton, Zhuo Wang, Cecilia Balzano, et al.
Autophagy|December 4, 2009
Transglutaminase 2 is involved in autophagosome maturationManuela D'Eletto, Maria Grazia Farrace, Laura Falasca, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Plos One|October 17, 2013
Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgACristina Antonella Nadalutti, Ilma Rita Korponay-Szabo, Katri Kaukinen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2010
Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?Linghong Huang, John L Haylor, Marie Fisher, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 18, 2008
Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarringMarie Fisher, Richard A Jones, Linghong Huang, et al.
The Journal of Biological Chemistry|October 9, 2010
RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signalingZhuo Wang, Russell J Collighan, Stephane R Gross, et al.
Intensive Care Medicine|January 31, 2002
Continuous versus intermittent renal replacement therapy: a meta-analysisJohn A Kellum, Derek C Angus, John P Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2008
Synthesis of potent water-soluble tissue transglutaminase inhibitorsMartin Griffin, Alexandre Mongeot, Russell Collighan, et al.
Frontiers in Oncology|December 12, 2022
Corrigendum: <i>CDKN2A</i> determines mesothelioma cell fate to EZH2 inhibitionGiulia Pinton, Zhuo Wang, Cecilia Balzano, et al.
The Journal of Biological Chemistry|May 24, 2008
Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signalingDilek Telci, Zhuo Wang, Xiaoling Li, et al.
Frontiers in Oncology|July 19, 2021
<i>CDKN2A</i> Determines Mesothelioma Cell Fate to EZH2 InhibitionGiulia Pinton, Zhuo Wang, Cecilia Balzano, et al.
Autophagy|December 4, 2009
Transglutaminase 2 is involved in autophagosome maturationManuela D'Eletto, Maria Grazia Farrace, Laura Falasca, et al.
Pageof 8